The Canadian Cancer Research Alliance

Effective January 1st, 2025, the CCRA Advisory Board welcomes two new patient and family representatives, Adrienne Co-Dyre and Chantale Thurston, both well known cancer research advocates. Adrienne has used her accumulated knowledge and experience to inspire changes in policy, research, and communication around pediatric cancer treatments and has been instrumental in establishing Helena’s Hope, the Pediatric Cancer Priority Setting Partnership, and ACCESS, a pan-Canadian consortium that aims ...

The CCRA Awards, initiated in 2011, recognize and celebrate, on a biennial basis, individuals who have had a remarkable impact on cancer research and the cancer research community. We are seeking nominees for our four award categories: outstanding research, distinguished service, exceptional leadership, and exceptional leadership in patient involvement (see details at https://www.ccra-acrc.ca/ccra-awards/). The 2025 nomination form can be downloaded here and contains further details, includin...

Over the last 2 years, Dr. Perri Tutelman, Chantale Thurston, and Dr. Fiona Schulte, in collaboration with the James Lind Alliance (JLA), worked with the adolescent and young adult cancer (AYA) community to establish what research topics matter most to patients, their loved ones, and clinicians. This week they launched the top 10 cancer research priorities. To see them in full, go to https://www.ayacancerpsp.ca/top-10-priorities.

Effective October 9, 2024, the CCRA Advisory Board voted to modify the Exceptional Leadership in Cancer Research to the “Philip E. Branton Award for Exceptional Leadership in Cancer Research” to acknowledge and recognize Dr. Branton’s pivotal role in the creation of CCRA and his extraordinary contribution to Canada’s cancer research community. Dr. Branton was the inaugural recipient of this award when the program was initiated in 2011. Dr. Branton obtained his PhD from the Ontario Cancer I...